
life science companies that transform the lives of patients worldwide
Improving patients lives
(Nasdaq: AUPH, TSX: AUP)

life science companies that transform the lives of patients worldwide
Acquired by UCB

life science companies that transform the lives of patients worldwide
Building Better Biologics
(NYSE: ZYME)

Acquired by Gilead Sciences
$11.2B
life science companies that transform the lives of patients worldwide

life science companies that transform the lives of patients worldwide
The immune system preserved
(Nasdaq: GTHX)

ICIZED.
Acquired by Stryker
$1.65B
life science companies that transform the lives of patients worldwide

Severe Asthma
FORMED.
Acquired by Cephalon
$550 million
life science companies that transform the lives of patients worldwide
Lumira Ventures partners with exceptional entrepreneurs to build life science companies that transform the lives of patients worldwide.
Trending
Grading Canada’s Health and Innovation Response to COVID-19
December 21, 2020
As we come to the end of 2020 with the first vaccines by Pfizer/BioNTech and Moderna now approved by the FDA and Health Canada, it seems like an appropriate time to reflect on how Canada has... Learn More
Lumira co-leads $12.8 Million raise in Cyrano Therapeutics
December 10, 2020
Cyrano Therapeutics, a clinical stage regenerative medicine company developing a novel intranasal therapy for smell and flavor restoration, has raised $12.8 million in a Series A financing led by... Learn More
enGene Receives Fast Track Designation for EG-70 for the Treatment of Non-Muscle Invasive Bladder Cancer
December 4, 2020
enGene Inc., A biotechnology company developing non-viral gene therapies for local administration into mucosal tissues enabled by its proprietary DDX platform, announced today that the U.S. Food... Learn More
Lumira Ventures Appoints Special Advisors and Venture Partner
November 18, 2020
Veteran Pharmaceutical Industry Executives Will Advise Portfolio Companies and Investment Team TORONTO, November 18, 2020 - Lumira Ventures, a leading North American healthcare venture capital... Learn More
Team Lumira
Our investment team of 12 professionals has over 225 years of collective experience founding, managing and investing in healthcare and life sciences companies. We value collaboration, creativity and challenging conventional wisdom.
Philanthropy
Lumira donates a portion of partner time and profits to support the research, translational medicine and healthcare access missions of over a dozen leading healthcare foundations.
Contact Us
Our team is strategically situated across North America to identify innovative companies within and outside the traditional start-up hubs, and help them access capital, talent and strategic partners.

Toronto
141 Adelaide Street
Suite 770
Toronto, ON
Canada, M5H 3L5
416.213.4223

Montreal
Espace CDPQ
3, Place Ville Marie
Bureau 12350, Niveau L
Montreal, QC
Canada, H3B 0E7
514.844.6927

Vancouver
1021 West Hastings Street,
9th floor
Vancouver, BC
Canada, V6E 0C3
604.558.5156

Boston
303 Wyman Street
Suite 300
Waltham, MA,
USA, 02451-1208
781.530.3868